Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
The Food and Drug Administration (FDA or we) is requesting data and information to help make an evidence-based determination that balances food safety, regulatory clarity, and industry interest regarding a potential update to the acceptable market name for the following fish: Sebastes alutus, Sebastes borealis, Sebastes ciliatus, Sebastes crameri, Sebastes entomelas, Sebastes flavidus, Sebastes goodei, Sebastes levis, Sebastes melanops, Sebastes miniatus, Sebastes ovalis, Sebastes paucispinis, Sebastes pinniger, Sebastes proriger, Sebastes reedi, Sebastes ruberrimus, Sebastes rufus, and Sebastes serranoides.
Published
Apr 1, 2026
Comments Close
May 1, 2026(14d)
Citation
91 FR 16200
Agencies
2
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
Docket No. FDA-2026-N-2741